Findings from Innovative Medicines Initiative project BigData@Heart underscore the importance of accounting for sex-based differences in medical research.

A new non-profit company is delivering fully characterised, lab-based paediatric tumour models for testing potential cancer therapies, thanks to the IMI ITCC-P4 project’s results.

Results from IMI project COMBACTE-CARE show that – if approved – a new combination of drugs could help in the fight against some of the most dangerous drug-resistant bacteria.

The standards were developed by a multi-stakeholder group including people living with asthma as well as doctors, pharmaceutical companies, and health policymakers.

The European Platform for Neurodegenerative Diseases has created a Cohort Catalogue to help to accelerate the hunt for biological markers of neurodegenerative diseases like Alzheimer's and Parkinson's diseases.

Using smartphones to self-report and monitor thinking difficulties could help to monitor and manage depression, according to new research from IMI project RADAR-CNS.

Data gathered during Innovative Medicines Initiative project DIRECT helped scientists to pinpoint genetic variants associated with a good response to diabetes drugs called GLP-1 agonists.

Innovative Medicines Initiative (IMI) project iConsensus draws on the agility and specialist knowledge of SMEs and the know-how of academic experts to make biological drug development faster, cheaper and more efficient.

The research, by Innovative Medicines Initiative (IMI) project IDEA-FAST, involved people with neurodegenerative and inflammatory diseases, where fatigue can have a major impact on patients’ quality of life.

Innovative Medicines Initiative project UNITE4TB explored how low- and middle-income countries can roll out the molecular diagnostic tests needed to determine the best course of treatment for people diagnosed with TB.